Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global 多楔带 Market by Type (Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies), By Application (Hospital Pharmacy, Retail Pharmacy, Drug Stores) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global 多楔带 Market by Type (Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies), By Application (Hospital Pharmacy, Retail Pharmacy, Drug Stores) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 307854 4200 Medical Care 377 140 Pages 4.9 (33)
                                          

Market Overview:


The global glucocorticoid market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of autoimmune diseases, rising geriatric population, and growing demand for better treatment options. The symptomatic treatment segment is expected to dominate the market during the forecast period owing to its high usage rates for treating various autoimmune diseases. By application, the hospital pharmacy segment is expected to account for a major share of the global glucocorticoid market during the forecast period owing to increasing number of hospitals and growing demand for better treatments options.


Global 多楔带 Industry Outlook


Product Definition:


多楔带 is a type of Chinese cabbage. It is important because it is a source of vitamin C and other nutrients.


Symptomatic Treatment:


The global symptomatic treatment market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders & respiratory diseases along with increasing awareness about various treatments available are some growth factors for the market.


Intermediate Corticosteroid Therapies:


Intermediate corticosteroid therapies are used to treat a wide range of diseases such as asthma, allergic rhinitis, and other respiratory disorders. These medications are also used in the treatment of immune-mediated diabetes mellitus and multiple sclerosis. The global intermediate corticosteroid market is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence of respiratory diseases coupled with rising awareness about these drugs among patients & healthcare professionals.


Application Insights:


The global demand for prednisone was valued at USD 5.5 billion in 2017 and is projected to grow with the advancement of the disease modifying antirheumatic drug therapies. Prednisone is used in various formulations such as oral tablets, oral suspension, intravenous injection and intranasal spray among others. The Disease Modifying Antirheumatic Drug (DMARD) segment dominated the overall market by application owing to its high usage rate across all major applications globally.


In addition, intermediate corticosteroid therapies are also expected to witness lucrative growth over the forecast period due to their rising use rate across hospital pharmacies globally coupled with retail pharmacies growing penetration rates in developing countries such as India & China over recent years.


Regional Analysis:


North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of rheumatoid arthritis are some factors responsible for its growth. In addition, growing awareness about early diagnosis and treatment is expected to drive the regional market during the forecast period.


Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rising healthcare expenditure by governments as well as individuals in order to obtain better healthcare services at lower costs coupled with improving infrastructure facilities in developing countries such as India and China. These factors are expected to boost ‘Global 多楔带 Market’ revenue during the estimated time frame.


Growth Factors:


  • Increasing demand from the automotive and construction industries.
  • Growing popularity of electric vehicles.
  • Expansion of the middle class in developing countries.
  • Proliferation of online shopping platforms.
  • Emergence of new transportation modes (e-commerce, ride-sharing, etc.).

Scope Of The Report

Report Attributes

Report Details

Report Title

多楔带 Market Research Report

By Type

Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies

By Application

Hospital Pharmacy, Retail Pharmacy, Drug Stores

By Companies

Sanofi, Pfizer, Roche, Johnson & Johnson, AbbVie, Eli Lilly, Amgen, Sobi, Bristol-Myers Squibb

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

140

Number of Tables & Figures

98

Customization Available

Yes, the report can be customized as per your need.


Global 多楔带 Market Report Segments:

The global 多楔带 market is segmented on the basis of:

Types

Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacy, Retail Pharmacy, Drug Stores

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Sanofi
  2. Pfizer
  3. Roche
  4. Johnson & Johnson
  5. AbbVie
  6. Eli Lilly
  7. Amgen
  8. Sobi
  9. Bristol-Myers Squibb

Global 多楔带 Market Overview


Highlights of The 多楔带 Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Symptomatic Treatment
    2. Intermediate Corticosteroid Therapies
    3. Disease Modifying Antirheumatic Drug Therapies
  1. By Application:

    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Drug Stores
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the 多楔带 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global 多楔带 Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


多楔带 is a letter used in the Swedish alphabet. It is pronounced "ahks-ehk ahz".

Some of the major companies in the 多楔带 market are Sanofi, Pfizer, Roche, Johnson & Johnson, AbbVie, Eli Lilly, Amgen, Sobi, Bristol-Myers Squibb.

The ¥¤å¡¦¥€¥¸¦ market is expected to register a CAGR of 5.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 多楔带 Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 多楔带 Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 多楔带 Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the 多楔带 Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global 多楔带 Market Size & Forecast, 2020-2028       4.5.1 多楔带 Market Size and Y-o-Y Growth       4.5.2 多楔带 Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Symptomatic Treatment
      5.2.2 Intermediate Corticosteroid Therapies
      5.2.3 Disease Modifying Antirheumatic Drug Therapies
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital Pharmacy
      6.2.2 Retail Pharmacy
      6.2.3 Drug Stores
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global 多楔带 Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 多楔带 Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Symptomatic Treatment
      9.6.2 Intermediate Corticosteroid Therapies
      9.6.3 Disease Modifying Antirheumatic Drug Therapies
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital Pharmacy
      9.10.2 Retail Pharmacy
      9.10.3 Drug Stores
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Symptomatic Treatment
      10.6.2 Intermediate Corticosteroid Therapies
      10.6.3 Disease Modifying Antirheumatic Drug Therapies
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital Pharmacy
      10.10.2 Retail Pharmacy
      10.10.3 Drug Stores
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Symptomatic Treatment
      11.6.2 Intermediate Corticosteroid Therapies
      11.6.3 Disease Modifying Antirheumatic Drug Therapies
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital Pharmacy
      11.10.2 Retail Pharmacy
      11.10.3 Drug Stores
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Symptomatic Treatment
      12.6.2 Intermediate Corticosteroid Therapies
      12.6.3 Disease Modifying Antirheumatic Drug Therapies
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital Pharmacy
      12.10.2 Retail Pharmacy
      12.10.3 Drug Stores
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Symptomatic Treatment
      13.6.2 Intermediate Corticosteroid Therapies
      13.6.3 Disease Modifying Antirheumatic Drug Therapies
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital Pharmacy
      13.10.2 Retail Pharmacy
      13.10.3 Drug Stores
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 多楔带 Market: Competitive Dashboard
   14.2 Global 多楔带 Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Sanofi
      14.3.2 Pfizer
      14.3.3 Roche
      14.3.4 Johnson & Johnson
      14.3.5 AbbVie
      14.3.6 Eli Lilly
      14.3.7 Amgen
      14.3.8 Sobi
      14.3.9 Bristol-Myers Squibb

Our Trusted Clients

Contact Us